Tyra Biosciences posts 2026 shareholder vote results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tyra Biosciences, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 28, 2026. Stockholders elected three directors: Habib J. Dable, Susan Moran, M.D., M.S.C.E., and Robert More. Each nominee received over 41 million votes in favor, with 8,377,977 broker non-votes recorded on each director item.
Stockholders also approved another meeting proposal with 53,092,820 votes for, 1,316 against, and 3,246 abstentions, and no broker non-votes.
8-K Event Classification
Key Figures
Key Terms
Annual Meeting of Stockholders financial
broker non-votes financial
emerging growth company regulatory
Nasdaq Global Select Market financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tyra Biosciences (TYRA) report from its 2026 Annual Meeting?
Which directors were elected at Tyra Biosciences (TYRA) 2026 Annual Meeting?
How many votes did the Tyra Biosciences (TYRA) 2026 proposal receive?
What were the vote totals for Tyra Biosciences (TYRA) director Habib J. Dable?
How did stockholders vote on director Susan Moran at Tyra Biosciences (TYRA)?
What were the voting results for Tyra Biosciences (TYRA) director Robert More?
AI-generated analysis. How Rhea-AI works. Not financial advice.